3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
8
Lymphoid
6
Sarcoma
4
Other hematologic neoplasm
2
Genitourinary
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
110
Leukemia
58
Lymphoma
41
Burkitt Lymphoma
35
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
25
Lymphoma, Large B-Cell, Diffuse
19
Lymphoma, Non-Hodgkin
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Recurrence
13
Lymphoma, Large-Cell, Anaplastic
11
Lymphoma, Follicular
11
Lymphoma, Mantle-Cell
10
Lymphoma, Large-Cell, Immunoblastic
10
Lymphoma, B-Cell, Marginal Zone
10
Leukemia, Biphenotypic, Acute
10
Multiple Myeloma
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Blast Crisis
7
Myelodysplastic Syndromes
6
Leukemia, Myeloid, Acute
6
Immunoblastic Lymphadenopathy
6
Hodgkin Disease
6
Hematologic Neoplasms
5
Myeloproliferative Disorders
4
Lymphoma, T-Cell, Peripheral
4
Lymphoma, T-Cell, Cutaneous
4
Leukemia, Myeloid, Accelerated Phase
4
Dendritic Cell Sarcoma, Interdigitating
4
Waldenstrom Macroglobulinemia
3
Sezary Syndrome
3
Interventions
Doxorubicin
2
hydrocortisone hemisuccinate
1
Vincristine
1
Razoxane
1
Radiotherapy
1
Prednisone
1
Methotrexate
1
Mercaptopurine
1
Medical History Taking
1
Leucovorin
1
Laser-Doppler Flowmetry
1
Hydrocortisone
1
Exercise
1
Electrocardiography
1
Echocardiography, Stress
1
Dexrazoxane
1
Cytarabine
1
Blood Cell Count
1
Asparaginase
1
Anthropometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Doxorubicin
×
Other hematologic neoplasm
×
Clear all
NCT01095926
2013-06-28
Doxo
University Hospital Muenster
Phase 2
Completed
101 enrolled
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled